These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15499488)

  • 21. Use of keratin 35betaE12 as an adjunct in the diagnosis of mammary intraepithelial neoplasia-ductal type--benign and malignant intraductal proliferations.
    Moinfar F; Man YG; Lininger RA; Bodian C; Tavassoli FA
    Am J Surg Pathol; 1999 Sep; 23(9):1048-58. PubMed ID: 10478664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amplification of growth regulatory genes in intraductal breast cancer is associated with higher nuclear grade but not with the progression to invasiveness.
    Glöckner S; Lehmann U; Wilke N; Kleeberger W; Länger F; Kreipe H
    Lab Invest; 2001 Apr; 81(4):565-71. PubMed ID: 11304576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fine-needle aspiration cytology of ductal hyperplasia with and without atypia and ductal carcinoma in situ.
    Sneige N; Staerkel GA
    Hum Pathol; 1994 May; 25(5):485-92. PubMed ID: 8200642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of astrocyte elevated gene-1, basic-fibroblast growth factor, beta-catenin, Ki-67, tumor necrosis factor-alfa with prognostic parameters in ductal carcinomas and ductal intraepithelial neoplasms.
    Erdem H; Gundogdu B; Ankarali H; Yasar M; Sener E; Oktay M; Bahadir A; Uzunlar AK; Gursan N; Ozaydin I; Sahiner C
    Niger J Clin Pract; 2015; 18(5):638-43. PubMed ID: 26096243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C-Erb-b2 oncogene expression in intraductal proliferative lesions of the breast.
    Eren F; Calay Z; Durak H; Eren B; Comunoğlu N; Aydin O
    Bosn J Basic Med Sci; 2012 Feb; 12(1):41-50. PubMed ID: 22364303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extensive apoptosis in ductal carcinoma in situ of the breast.
    Bodis S; Siziopikou KP; Schnitt SJ; Harris JR; Fisher DE
    Cancer; 1996 May; 77(9):1831-5. PubMed ID: 8646681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amplification of CCND1 and expression of its protein product, cyclin D1, in ductal carcinoma in situ of the breast.
    Simpson JF; Quan DE; O'Malley F; Odom-Maryon T; Clarke PE
    Am J Pathol; 1997 Jul; 151(1):161-8. PubMed ID: 9212742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microvessel density and distribution in ductal carcinoma in situ of the breast.
    Guidi AJ; Fischer L; Harris JR; Schnitt SJ
    J Natl Cancer Inst; 1994 Apr; 86(8):614-9. PubMed ID: 7511693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is there a low-grade precursor pathway in breast cancer?
    King TA; Sakr RA; Muhsen S; Andrade VP; Giri D; Van Zee KJ; Morrow M
    Ann Surg Oncol; 2012 Apr; 19(4):1115-21. PubMed ID: 21935747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterogeneous expression of nm23 gene product in noninvasive breast carcinoma.
    Simpson JF; O'Malley F; Dupont WD; Page DL
    Cancer; 1994 May; 73(9):2352-8. PubMed ID: 7513249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of HER2 amplification status among breast cancer subgroups offers new insights in pathways of breast cancer progression.
    Lambein K; Van Bockstal M; Vandemaele L; Van den Broecke R; Cocquyt V; Geenen S; Denys H; Libbrecht L
    Virchows Arch; 2017 Nov; 471(5):575-587. PubMed ID: 28567637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
    Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Satomi S; Sasano H
    Anticancer Res; 2000; 20(2B):1101-8. PubMed ID: 10810403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HER2 status in pure ductal carcinoma in situ and in the intraductal and invasive components of invasive ductal carcinoma determined by fluorescence in situ hybridization and immunohistochemistry.
    Park K; Han S; Kim HJ; Kim J; Shin E
    Histopathology; 2006 May; 48(6):702-7. PubMed ID: 16681686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The evaluation of the immunoexpression of Her2÷neu oncoprotein in ductal carcinoma in situ in association with invasive ductal carcinoma of the breast.
    Fota GL; Stepan A; Ciurea RN
    Rom J Morphol Embryol; 2012; 53(3 Suppl):805-10. PubMed ID: 23188444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ductal carcinoma in situ and ductal carcinoma in situ with microinvasion: correlation of FDG uptake with histological and biological prognostic factors.
    Seo YY; Yoo IR; Park SY; Oh JK; Kim SH; Sohn HS
    Breast Cancer; 2017 May; 24(3):353-361. PubMed ID: 27312540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of the cell death genes BNip3 and NIX in ductal carcinoma in situ of the breast; correlation of BNip3 levels with necrosis and grade.
    Sowter HM; Ferguson M; Pym C; Watson P; Fox SB; Han C; Harris AL
    J Pathol; 2003 Dec; 201(4):573-80. PubMed ID: 14648660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Similarity in expression of cell cycle proteins between in situ and invasive ductal breast lesions of same differentiation grade.
    Mommers EC; Leonhart AM; Falix F; Michalides R; Meijer CJ; Baak JP; Diest PJ
    J Pathol; 2001 Jul; 194(3):327-33. PubMed ID: 11439365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential Gene Expression in Ductal Carcinoma In Situ of the Breast Based on ERBB2 Status.
    Agosto-Arroyo E; Isayeva T; Wei S; Almeida JS; Harada S
    Cancer Control; 2017 Jan; 24(1):102-110. PubMed ID: 28178722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinicopathologic features and treatment of ductal carcinoma in situ of the breast].
    Zhou L; Wang Y; Song X; Du JW; Pei F; Huang LP; Wang WY; Liu ZB; Pan RQ
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3035-8. PubMed ID: 16324401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunohistochemical analysis of p53 and c-erbB-2 in breast cancer].
    Castiglioni T; Elsner B; Curutchet HP; Montesinos M; Debonis D
    Medicina (B Aires); 1995; 55(5 Pt 1):415-20. PubMed ID: 8728771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.